| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.96B | +28.3% |
| Cost of Revenue | $3.77B | +24.4% |
| Gross Profit | $1.19B | +42.7% |
| R&D Expense | $351.0M | -2.0% |
| SG&A Expense | $307.0M | -15.2% |
| Operating Income | $16.0M | +105.6% |
| Pre-tax Income | $22.0M | +109.0% |
| Income Tax | $3.0M | +50.0% |
| Net Income | $19.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $903.0M | +49.3% |
| Accounts Receivable | $115.0M | +66.7% |
| Inventory | $118.0M | +0.0% |
| Current Assets | $1.98B | +25.8% |
| Total Assets | $2.41B | +23.0% |
| Current Liabilities | $811.0M | +22.3% |
| Total Liabilities | $863.0M | +13.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $360.0M | +166.7% |
| Investing Cash Flow | -$39.0M | +54.7% |
| Financing Cash Flow | $18.0M | -71.4% |
| +107.7% |
| EPS (Basic) | $0.03 | +106.5% |
| EPS (Diluted) | $0.03 | +106.4% |
| Stockholders' Equity |
| $1.54B |
| +29.4% |